JavaScript is NOT enabled !

Please enable JavaScript.

Article

PubMed

This record comes from PubMed

International Myeloma Working Group recommendations for global myeloma care

Ludwig, H
Author Ludwig, H Department of Medicine I, Center of Oncology, Hematology and Palliative Care, Wilhelminenspital, Vienna, Austria
Miguel, J S
Author Miguel, J S Clinica Universidad de Navarra, Pamplona, Spain
Dimopoulos, M A
Author Dimopoulos, M A Department of Clinical Therapeutics, University of Athens, School of Medicine, Athens, Greece
Palumbo, A
Author Palumbo, A Myeloma Unit, Division of Hematology, University of Torino, Torino, Italy
Garcia Sanz, R
Author Garcia Sanz, R Servicio de Hematologia, Hospital Universitario de Salamanca, Salamanca, Spain
Powles, R
Author Powles, R Parkside Cancer Centre, London, UK
Lentzsch, S
Author Lentzsch, S Columbia University Medical Center, New York, NY, USA
Ming Chen, W
Author Ming Chen, W Chaoyang Hospital, Capital Medical University, Beijing, China
Hou, J
Author Hou, J Shanghai Chang Zheng Hospital, Shanghai, China
Jurczyszyn, A
Author Jurczyszyn, A Department of Hematology, University Hospital, Cracow, Poland
Romeril, K
Author Romeril, K Haematology Department, Wellington Hospital, Wellington, New Zealand
Hajek, R
Author Hajek, R Department of Internal Medicine, University of Ostrava, Ostrava, Czech Republic
Terpos, E
Author Terpos, E Department of Clinical Therapeutics, University of Athens, School of Medicine, Athens, Greece
Shimizu, K
Author Shimizu, K Nagoya City Midori General Hospital, Nagoya, Japan
Joshua, D
Author Joshua, D Institute of Hematology, Royal Prince Alfred Hospital, Sydney, Australia
Hungria, V
Author Hungria, V Santa Casa de Sao Paulo, Sao Paolo, Brazil
Rodriguez Morales, A
Author Rodriguez Morales, A Bonco Metro Politano de Sangre, Caracas, Venezuela
Ben-Yehuda, D
Author Ben-Yehuda, D Department of Hematology, Hadassah-Hebrew University Medical Center, Jerusalem, Israel
Sondergeld, P
Author Sondergeld, P University of Giessen, Giessen, Germany
Zamagni, E
Author Zamagni, E Istituto di Ematologia Seràgnoli, Università degli Studi di Bologna, Bologna, Italy
Durie, B
Author Durie, B Cedars-Sinai Outpatient Cancer Center, Los Angeles, CA, USA

Leukemia. 2014 May ; 28 (5) : 981-92. [epub] 20131009

ISSN 1476-5551 | 0887-6924
Source

Language English Country Great Britain, England Media print-electronic

Document type Journal Article, Review

Persistent link https://www.medvik.cz/link/pmid24177258

PubMed 24177258
DOI 10.1038/leu.2013.293
PII: leu2013293
Knihovny.cz E-resources

MeSH
Humans MeSH
Multiple Myeloma physiopathology therapy MeSH
Monitoring, Physiologic MeSH
Recurrence MeSH
Treatment Outcome MeSH
Check Tag
Humans MeSH
Publication type
Journal Article MeSH
Review MeSH

Recent developments have led to remarkable improvements in the assessment and treatment of patients with multiple myeloma (MM). New technologies have become available to precisely evaluate the biology and extent of the disease, including information about cytogenetics and genetic abnormalities, extramedullary manifestations and minimal residual disease. New, more effective drugs have been introduced into clinical practice, which enable clinicians to significantly improve the outcome of patients but also pose new challenges for the prevention and management of their specific side effects. Given these various new options and challenges, it is important to identify the minimal requirements for diagnosis and treatment of patients, as access to the most sophisticated advances may vary depending on local circumstances. Here, we propose the minimal requirements and possible options for diagnosis, monitoring and treatment of patients with multiple myeloma.

Bonco Metro Politano de Sangre Caracas Venezuela

Cedars Sinai Outpatient Cancer Center Los Angeles CA USA

Chaoyang Hospital Capital Medical University Beijing China

Clinica Universidad de Navarra Pamplona Spain

Columbia University Medical Center New York NY USA

Department of Clinical Therapeutics University of Athens School of Medicine Athens Greece

Department of Hematology Hadassah Hebrew University Medical Center Jerusalem Israel

Department of Hematology University Hospital Cracow Poland

Department of Internal Medicine University of Ostrava Ostrava Czech Republic

Department of Medicine 1 Center of Oncology Hematology and Palliative Care Wilhelminenspital Vienna Austria

Haematology Department Wellington Hospital Wellington New Zealand

Institute of Hematology Royal Prince Alfred Hospital Sydney Australia